Medeon Biodesign Current Valuation vs. Price To Sales
| 6499 Stock | TWD 42.90 0.70 1.61% |
For Medeon Biodesign profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Medeon Biodesign to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Medeon Biodesign utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Medeon Biodesign's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Medeon Biodesign over time as well as its relative position and ranking within its peers.
Medeon |
Medeon Biodesign Price To Sales vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Medeon Biodesign's current stock value. Our valuation model uses many indicators to compare Medeon Biodesign value to that of its competitors to determine the firm's financial worth. Medeon Biodesign is the top company in current valuation category among its peers. It also is number one stock in price to sales category among its peers . The ratio of Current Valuation to Price To Sales for Medeon Biodesign is about 171,414,080 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medeon Biodesign's earnings, one of the primary drivers of an investment's value.Medeon Current Valuation vs. Competition
Medeon Biodesign is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Medical Instruments & Supplies industry is presently estimated at about (929.66 Billion). Medeon Biodesign adds roughly 3.37 Billion in current valuation claiming only tiny portion of all equities under Medical Instruments & Supplies industry.
Medeon Price To Sales vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Medeon Biodesign |
| = | 3.37 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Medeon Biodesign |
| = | 19.67 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Medeon Price To Sales Comparison
Medeon Biodesign is currently under evaluation in price to sales category among its peers.
Medeon Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Medeon Biodesign. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Medeon Biodesign position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Medeon Biodesign's important profitability drivers and their relationship over time.
Use Medeon Biodesign in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medeon Biodesign position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medeon Biodesign will appreciate offsetting losses from the drop in the long position's value.Medeon Biodesign Pair Trading
Medeon Biodesign Pair Trading Analysis
The ability to find closely correlated positions to Medeon Biodesign could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medeon Biodesign when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medeon Biodesign - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medeon Biodesign to buy it.
The correlation of Medeon Biodesign is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medeon Biodesign moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medeon Biodesign moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medeon Biodesign can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Medeon Biodesign position
In addition to having Medeon Biodesign in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Target Outcome ETFs Thematic Idea Now
Target Outcome ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Outcome ETFs theme has 93 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Outcome ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Medeon Stock Analysis
When running Medeon Biodesign's price analysis, check to measure Medeon Biodesign's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medeon Biodesign is operating at the current time. Most of Medeon Biodesign's value examination focuses on studying past and present price action to predict the probability of Medeon Biodesign's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medeon Biodesign's price. Additionally, you may evaluate how the addition of Medeon Biodesign to your portfolios can decrease your overall portfolio volatility.